The Challenge of Targeting Undruggable Proteins

What is an undruggable target?

An undruggable target refers to a protein or biological molecule that is challenging or extremely difficult to modulate or inhibit using traditional small-molecule drugs. In pharmaceutical research, scientists often aim to develop drugs that can specifically target certain proteins or molecules implicated in diseases in order to treat or cure those conditions.

However, not all proteins or molecules are easily targeted by drugs due to their structural characteristics or functions within the human body. Undruggable targets typically possess properties that make them resistant to binding by small molecules or render them inaccessible to conventional drug delivery methods

There are several reasons why a target might be considered undruggable:

1. Protein-protein interactions: Some diseases are caused by interactions between different proteins in the body. However, disrupting these interactions with small-molecule drugs is notoriously challenging due to the large and complex interface between the proteins involved

2. Intracellular proteins: Proteins that reside within cells, particularly those located in specific compartments, such as within the nucleus or membrane, pose difficulties for drug delivery. These proteins may be difficult to access by small molecules due to barriers like cell membranes, making it challenging to design drugs that can effectively reach their intracellular targets

3. Structural complexity: Certain proteins have highly complex three-dimensional structures, with intricate folds and multiple binding sites. These characteristics can make it difficult to design small molecules that can bind to these targets with sufficient specificity and affinity

4. Lack of suitable binding pockets: For a small-molecule drug to effectively interact with a protein, it needs to fit into a specific binding pocket or site on the target molecule. Undruggable targets often lack such binding pockets, making it difficult to develop drugs that can effectively engage with them

The difficulty in targeting undruggable targets has driven scientists to explore alternative strategies. These include the development of approaches such as antibody-based therapies, gene therapies, or small interfering RNA (siRNA) technologies, which can target proteins indirectly or modulate their activity in different ways

In recent years, advancements in fields like structural biology, computational modeling, and novel drug delivery technologies have increased the potential for targeting traditionally undruggable proteins. Researchers are also exploring innovative techniques, such as using small molecules as probes to better understand undruggable targets or developing techniques to enhance the delivery of drugs to intracellular compartments

While the quest to target undruggable targets remains challenging, ongoing research efforts continue to push the boundaries of drug discovery, expanding our understanding of complex biological systems, and offering hope for future therapeutic interventions

More Answers: